AstraZeneca Stock Forecast

Stock Price Forecast

According to 24 analysts polled by S&P Global, AstraZeneca stock has a consensus rating of "Buy" and an average price target of 16,330p. The average 1-year stock price forecast is 12.61% higher than the current stock price, while the lowest is 11,392p (-21.45%) and the highest is 18,881p (+30.19%).

Price Target: 16,330p (+12.61%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	11,392p	16,330p	16,774p	18,881p
Change	-21.45%	+12.61%	+15.67%	+30.19%

Analyst Ratings

The average analyst rating for AstraZeneca stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	16	14	15	15	15	15
Buy	4	4	4	4	4	4
Hold	2	2	2	3	3	3
Sell	0	1	1	0	0	0
Strong Sell	1	1	1	1	1	1
Total	23	22	23	23	23	23

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Emmanuel Papadakis Deutsche Bank	Deutsche Bank	Sell Maintains 11,500p	Sell	Maintains	11,500p	-20.70%	Jun 30, 2026
James Gordon CFA Barclays	Barclays	Buy Maintains 16,500p	Buy	Maintains	16,500p	+13.78%	Jun 30, 2026
Richard Vosser J.P. Morgan	J.P. Morgan	Buy Maintains 16,000p	Buy	Maintains	16,000p	+10.33%	Jun 30, 2026
Sachin Jain Bank of America Securities	Bank of America Securities	Buy Reiterates 16,500p	Buy	Reiterates	16,500p	+13.78%	Jun 30, 2026
Michael Leuchten Jefferies	Jefferies	Buy Maintains 18,000p	Buy	Maintains	18,000p	+24.12%	Jun 26, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

63.33B

from 58.74B

7.82%

from 58.74B

Revenue Next Year

67.02B

from 63.33B

5.83%

from 63.33B

EPS This Year

10.30

from 9.16

12.42%

from 9.16

EPS Next Year

11.56

from 10.30

12.25%

from 10.30

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	37.42B	44.35B	45.81B	54.07B	58.74B	63.33B
Revenue Growth	40.58%	18.53%	3.29%	18.04%	8.63%	7.82%
Gross Profit	25.41B	35.71B	37.77B	44.44B	47.99B	52.40B
Gross Margin	67.92%	80.52%	82.44%	82.18%	81.71%	82.75%
Operating Income	2.90B	8.81B	9.70B	12.93B	14.29B	21.23B
Net Income	112.00M	3.29B	5.96B	7.04B	10.23B	12.47B
EPS	-	-	-	-	9.16	10.30
EPS Growth	-	-	-	-	11.57%	12.42%
Forward PE	18.61	18.65	17.08	14.36	18.34	18.78
Dividend / Share	2.87	2.90	2.90	3.10	3.20	3.33
Dividend Growth	-	1.05%	-	6.90%	3.23%	4.21%
Free Cash Flow	-1.85B	12.49B	9.04B	8.46B	7.87B	10.04B
No. Analysts	-	-	-	-	-	24

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	64.8B
Avg	63.3B
Low	58.6B

Revenue Growth

Revenue Growth	2026	2027	2028
High	10.4%
Avg	7.8%
Low	-0.2%

EPS Forecast

EPS	2026	2027	2028
High	10.74
Avg	10.30
Low	10.07

EPS Growth

EPS Growth	2026	2027	2028
High	17.2%
Avg	12.4%
Low	9.9%